Venus Remedies Limited (BOM:526953)
726.40
-20.60 (-2.76%)
At close: Jan 23, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 9.71 billion as of January 23, 2026. Its market cap has increased by 129.44% in one year.
Market Cap
9.71B
Enterprise Value
7.50B
Revenue
6.99B
Ranking
n/a
PE Ratio
13.80
Stock Price
726.40
Market Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 9.71B, an increase of 3,898.54%. That is a compound annual growth rate of 18.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 9.99B | -2.61% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTK Healthcare | 13.67B |
| Kwality Pharmaceuticals | 11.52B |
| Syncom Formulations (India) | 11.48B |
| Fermenta Biotech | 9.56B |
| Lincoln Pharmaceuticals | 9.07B |
| Bharat Parenterals | 7.45B |
| Anuh Pharma | 7.31B |
| Fredun Pharmaceuticals | 7.10B |